Published in Liver Transpl on January 01, 2005
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. World J Gastroenterol (2014) 1.40
Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs (2011) 1.24
Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg (2007) 0.94
Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. PLoS One (2013) 0.88
Late-onset acute rejection after living donor liver transplantation. World J Gastroenterol (2006) 0.84
Steroid elimination is coming of age. Pediatr Nephrol (2005) 0.84
Metabolic and cardiovascular complications in the liver transplant recipient. Ann Gastroenterol (2015) 0.82
A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years. HPB (Oxford) (2012) 0.81
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients. J Transplant (2012) 0.80
Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol (2012) 0.79
Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials. Hepatol Int (2014) 0.78
Metabolic complications in liver transplant recipients. World J Gastroenterol (2016) 0.76
Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review. World J Gastroenterol (2014) 0.75
A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation. Transplant Res (2014) 0.75
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Obesity in general elective surgery. Lancet (2003) 7.22
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57
Kidney transplantation from donors without a heartbeat. N Engl J Med (2002) 4.85
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology (2009) 4.03
Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg (2012) 3.87
ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg (2014) 3.60
Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc (2008) 3.47
Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg (2006) 3.35
Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med (2008) 3.10
Evaluation and stages of surgical innovations. Lancet (2009) 3.04
Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98
New staging system and a registry for perihilar cholangiocarcinoma. Hepatology (2011) 2.89
Challenges in evaluating surgical innovation. Lancet (2009) 2.86
A multicenter randomized clinical trial of primary anastomosis or Hartmann's procedure for perforated left colonic diverticulitis with purulent or fecal peritonitis. Ann Surg (2012) 2.82
A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 2.64
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63
Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg (2007) 2.53
What is a surgical complication? World J Surg (2008) 2.53
Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg (2012) 2.49
Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg (2004) 2.49
Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg (2011) 2.42
Protective strategies against ischemic injury of the liver. Gastroenterology (2003) 2.37
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg (2013) 2.27
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res (2006) 2.26
Donor information for living donor liver transplantation: where can comprehensive information be found? Liver Transpl (2012) 2.21
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg (2005) 2.18
How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg (2005) 2.16
C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem (2002) 2.16
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet (2002) 2.12
Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant (2005) 2.06
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl (2003) 2.04
Surgical management of liver hydatid disease: subadventitial cystectomy versus resection of the protruding dome. World J Surg (2014) 2.04
Trainee satisfaction in surgery residency programs: modern management tools ensure trainee motivation and success. Surgery (2011) 2.04
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl (2003) 2.01
Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol (2005) 2.00
Impact of age over 75 years on outcomes after pancreaticoduodenectomy. J Surg Res (2012) 2.00
Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2007) 2.00
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet (2006) 1.97
Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg (2015) 1.95
Prospective evaluation of vacuum-assisted closure in abdominal compartment syndrome and severe abdominal sepsis. J Am Coll Surg (2007) 1.94
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut (2011) 1.87
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol (2006) 1.87
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol (2006) 1.87
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl (2006) 1.86
Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection. Liver Transpl (2005) 1.84
Atraumatic chylous ascites: systematic review on symptoms and causes. J Am Coll Surg (2011) 1.83
An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl (2007) 1.83
Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis (2007) 1.80
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg (2006) 1.79
From abstract to impact in cardiovascular research: factors predicting publication and citation. Eur Heart J (2012) 1.79
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Superiority of small islets in human islet transplantation. Diabetes (2007) 1.76
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl (2011) 1.75
Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg (2010) 1.73
Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol (2006) 1.73
Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series. Clin Transplant (2007) 1.70
The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg (2011) 1.69
Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg (2014) 1.69
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver Transpl (2005) 1.68
Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg (2003) 1.67
Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci U S A (2011) 1.66
Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg (2006) 1.66
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg (2004) 1.65
Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology (2003) 1.65
Hepatic function after genetically engineered pig liver transplantation in baboons. Transplantation (2010) 1.64
The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery (2009) 1.63
MRI: the new reference standard in quantifying hepatic steatosis? Gut (2011) 1.61
Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl (2006) 1.60
The International Registry on Hand and Composite Tissue Transplantation. Transplantation (2010) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58
Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg (2009) 1.56
First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation. Eur J Nucl Med Mol Imaging (2009) 1.56
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56
Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg (2008) 1.55
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54
Surgical management of complex liver trauma: a single liver transplant center experience. Am Surg (2012) 1.53
The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg (2007) 1.51
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant (2005) 1.50
Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transpl (2002) 1.49
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine. Transplantation (2004) 1.49
Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl (2013) 1.49
Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up. J Nucl Med (2008) 1.49
Anatomical variations of the hepatic artery: study of 932 cases in liver transplantation. Surg Radiol Anat (2006) 1.48
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation (2002) 1.48